Relapsed Pediatric ALL
8 clinical trials · Condition
◉ Watch Relapsed Pediatric ALL
| Record | Firm | Date |
|---|---|---|
| A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents (NCT05334823) | Chongqing Precision Biotech Co., Ltd | 2022-01-26 |
| Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) (NCT03938987) | University of Alberta | 2021-03-03 |
| TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia (NCT04033627) | Shanghai Children's Medical Center | 2020-11-10 |
| Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia (NCT04562792) | Children's Mercy Hospital Kansas City | 2020-05-08 |
| Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents (NCT04888468) | Chongqing Precision Biotech Co., Ltd | 2019-11-05 |
| ABT-751 With Chemotherapy for Relapsed Pediatric ALL (NCT00439296) | Therapeutic Advances in Childhood Leukemia Consortium | 2006-05-22 |
Track Relapsed Pediatric ALL automatically
Every clearance here is in the API, with alerts when new ones post.